GlaxoSmithKline PLC Director/PDMR Shareholding (4081V)
02 Diciembre 2019 - 11:52AM
UK Regulatory
TIDMGSK
RNS Number : 4081V
GlaxoSmithKline PLC
02 December 2019
GlaxoSmithKline plc (the 'Company')
Transaction notification
1. Details of PDMR/person closely associated with them
('PCA')
===================================================================
a) Name Mr B McNamara
=== ========================== =======================================
b) Position/status CEO, GSK Consumer Healthcare
=== ========================== =======================================
c) Initial notification/ Initial notification
amendment
=== ========================== =======================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== ===================================================================
a) Name GlaxoSmithKline plc
=== ========================== =======================================
b) LEI 5493000HZTVUYLO1D793
=== ========================== =======================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== ===================================================================
a) Description of American Depositary Shares ('ADSs')
the financial ISIN: US37733W1053
instrument
=== ========================== =======================================
b) Nature of the Sale of 25,000 ADSs
transaction
=== ========================== =======================================
c) Price(s) and Price(s) Volume(s)
volume(s) ----------
$45.3270 25,000
----------
=== ========================== =======================================
d) Aggregated information N/A (single transaction)
Aggregated volume
Price
=== ========================== =======================================
e) Date of the transaction 2019-11-29
=== ========================== =======================================
f) Place of the New York Stock Exchange (XNYS)
transaction
=== ========================== =======================================
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
DSHDLLFBKLFEFBB
(END) Dow Jones Newswires
December 02, 2019 12:52 ET (17:52 GMT)
Gsk (LSE:GSK)
Gráfica de Acción Histórica
De Feb 2024 a Mar 2024
Gsk (LSE:GSK)
Gráfica de Acción Histórica
De Mar 2023 a Mar 2024